CompletedNot Applicable

Peripheral Blood Biomarkers Associated With CIPN

100 participantsStarted 2014-11

Plain-language summary

The investigators are doing a research study that will teach us about the tingly pain that people develop when they get chemotherapy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of a tumor for which Platinums, Vinca Alkaloids, Bortezomib or Taxanes are indicated * No prior history of diabetic, anatomical or regional neuropathies (except pre-existing CIPN) * Age ≥ 18 years * Capable of understanding the investigational nature, potential risks and benefits of the study, and able to provide valid informed consent. Exclusion Criteria: * Inability to give consent * Inability to tolerate venipuncture for any reason * Age \< 18 years * Any known medical, surgical or psychiatric condition that may interfere with the conduct of the study or be detrimental to the donor in the opinion of the PI or caring physician * Consent Refusal by patient

What they're measuring

Collection of blood samples, medical history, CIPN symptomology (via questionnaire) and clinical laboratory data for a correlative evaluation of potential CIPN related molecular and cellular variance (biomarkers).

Timeframe: 3 years

Trial details

NCT IDNCT02661399

SponsorSt. Louis University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2017-05-08

View on ClinicalTrials.gov More Peripheral Neuropathy, Secondary to Drugs or Chemicals trials